Literature DB >> 15596322

Overview of incidence of sexually transmitted diseases in Kuwait.

Abdulwahab Al-Fouzan1, Nawaf Al-Mutairi.   

Abstract

Sexually transmitted diseases (STDs) are the most common infections afflicting mankind. According to the World Health Organization (WHO) estimates, the global incidence in 1995 of new cases of selected curable STDs, (gonorrhea, chlamydial infection, syphilis, and trichomoniasis) was 333 million. They are now the most common group of notifiable infectious diseases in most countries, particularly in the age group of 15-50 years, and in infants. They assume significance in view of the high incidence of acute infections, complications and sequelae, socioeconomic impact, role in increasing transmission of the human immunodeficiency virus (HIV). STDs are hyperendemic in many developing countries. In the industrialized world, diseases due to Chlamydia trachomatis, genital herpes virus, human papillomaviruses, and human immunodeficiency virus are now more important than the classical bacterial ones; whereas both groups remain major health problems in most developing countries. Their contribution to the spread of the HIV pandemic due to similar routes of transmission has brought attention to STDs in a forceful manner.

Entities:  

Mesh:

Year:  2004        PMID: 15596322     DOI: 10.1016/j.clindermatol.2004.07.002

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  2 in total

1.  Comparative study in infertile couples with and without Chlamydia trachomatis genital infection.

Authors:  Yuanchang Zhu; Biao Yin; Tonghua Wu; Lijun Ye; Chunmei Chen; Yong Zeng; Yaou Zhang
Journal:  Reprod Health       Date:  2017-01-13       Impact factor: 3.223

2.  Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.

Authors:  Duylinh Nguyen; Severin Gose; Lina Castro; Kathleen Chung; Kyle Bernstein; Micheal Samuel; Heidi Bauer; Mark Pandori
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.